Label: TRIPLE PREP SPF 40- avobenzone, octisalate, octocrylene, homosalate lotion
- NDC Code(s): 75936-621-01, 75936-621-02
- Packager: Supergoop, LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 5, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- PURPOSE
- KEEP OUT OF REACH OF CHILDREN
- WARNINGS
- INDICATIONS & USAGE
-
DOSAGE & ADMINISTRATION
Apply generously and evenly 15 minutes before sun exposure
Reapply at least every 2 hours
Use a water-resistant sunscreen if swimming or sweating
Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
Limit time in the sun, especially from 10 a.m.- 2 p.m.
Wear long-sleeved shirts, pants, hats, and sunglasses
Children under 6 months: Ask a doctor
-
INACTIVE INGREDIENT
Inactive Ingredients: Water, Isododecane, Butyloctyl Salicylate, Calcium Aluminum Borosilicate, Glycerin, Polymethylsilsesquioxane, Polyglycerin-3, Polyglyceryl-3 Lactate/Laurate, Ammonium Acryloyldimethyltaurate/VP Copolymer, Ectoin, Acrylates Crosspolymer, Gluconolactone, Arginine, Butylene Glycol, Sodium Benzoate, Polyacrylate Crosspolymer-6, Bisabolol, Tocopherol, Citric Acid, Niacinamide, Sodium Dilauramidoglutamide Lysine, Sodium Hyaluronate, Calcium Gluconate, Sodium Polyglutamate, Hydrolyzed Rhodophyceae Extract
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
TRIPLE PREP SPF 40
avobenzone, octisalate, octocrylene, homosalate lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:75936-621 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 5 g in 100 mL AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 3 g in 100 mL OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 6 g in 100 mL HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 7 g in 100 mL Inactive Ingredients Ingredient Name Strength SODIUM BENZOATE (UNII: OJ245FE5EU) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) ARGININE (UNII: 94ZLA3W45F) SODIUM DILAURAMIDOGLUTAMIDE LYSINE (UNII: MNJ7VPT2R5) POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK) AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG) TOCOPHEROL (UNII: R0ZB2556P8) ECTOINE (UNII: 7GXZ3858RY) LEVOMENOL (UNII: 24WE03BX2T) CALCIUM SODIUM PHOSPHATE (UNII: 7850XT8YDT) GLYCERIN (UNII: PDC6A3C0OX) POLYGLYCERIN-3 (UNII: 4A0NCJ6RD6) POLYGLYCERYL-3 LAURATE (UNII: Y9ZSR39D0E) HYALURONATE SODIUM (UNII: YSE9PPT4TH) SODIUM LAUROYL GLUTAMATE (UNII: NCX1UU2D33) ACRYLATES CROSSPOLYMER-4 (UNII: GEV2EL4D9G) GLUCONOLACTONE (UNII: WQ29KQ9POT) NIACINAMIDE (UNII: 25X51I8RD4) AMMONIUM ACRYLOYLDIMETHYLTAURATE, DIMETHYLACRYLAMIDE, LAURYL METHACRYLATE AND LAURETH-4 METHACRYLATE COPOLYMER, TRIMETHYLOLPROPANE TRIACRYLATE CROSSLINKED (45000 MPA.S) (UNII: Q7UI015FF9) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) CALCIUM GLUCONATE (UNII: SQE6VB453K) WATER (UNII: 059QF0KO0R) ISODODECANE (UNII: A8289P68Y2) BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:75936-621-02 1 in 1 BOX 07/12/2023 1 NDC:75936-621-01 50 mL in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 07/12/2023 Labeler - Supergoop, LLC (117061743)
